Ir directamente a la navegación principal Ir directamente a la búsqueda Ir directamente al contenido principal

Biochemical mode of action and differential activity of new ecdysone agonists against mosquitoes and moths

Producción científica: Article › revisión exhaustiva

27 Citas (Scopus)

Resumen

THQ (1-aroyl-4-(arylamino)-1,2,3,4-tetrahydroquinoline) compounds were identified by FMC Corporation in cell-based assays that used ecdysone receptors from Drosophila melanogaster, Heliothis virescens, or Plodia interpunctata. THQ compounds showed weak insecticidal activity against H. virescens and, therefore, were not developed further. Several ecdysone agonists based on THQ chemotype have been synthesized and tested for their activity against a number of EcRs in transactivation assays. The THQ compound, RG-120768, activated AaEcR (EcR from A. aegypti) but did not activate EcRs cloned from other insects. In transactivation assays, all six THQ ligands tested functioned through AaEcR but not through CfEcR (EcR from Choristoneura fumiferana). Three THQ compounds that showed higher activity in transactivation assays were tested in tobacco bud moth, H. virescens, and yellow fever mosquito, A. aegypti. These compounds showed higher activity in A. aegypti when compared to their activity in H. virescens. These data show that the THQ ligands are a new class of non-steroidal ecdysone agonists with preferential activity against mosquitoes.

Idioma originalEnglish
Páginas (desde-hasta)234-242
Número de páginas9
PublicaciónArchives of Insect Biochemistry and Physiology
Volumen58
N.º4
DOI
EstadoPublished - abr 2005

ASJC Scopus subject areas

  • Physiology
  • Biochemistry
  • Insect Science

Huella

Profundice en los temas de investigación de 'Biochemical mode of action and differential activity of new ecdysone agonists against mosquitoes and moths'. En conjunto forman una huella única.

Citar esto